Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL.

Lancet Neurol. 2008 Feb;7(2):129-35. doi: 10.1016/S1474-4422(08)70001-2. Epub 2008 Jan 10.

PMID:
18191617
2.
3.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
4.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.

PMID:
22710919
5.

Development and evaluation of compounds for imaging of beta-amyloid plaque by means of positron emission tomography.

Henriksen G, Yousefi BH, Drzezga A, Wester HJ.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S75-81. doi: 10.1007/s00259-007-0705-x. Review.

PMID:
18224319
6.

[Molecular imaging of beta-amyloid plaques in the brain].

Ono M.

Brain Nerve. 2007 Mar;59(3):233-40. Review. Japanese.

PMID:
17370649
7.

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi L, McHugh PF.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):250-64. Review.

8.

Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.

Kepe V, Huang SC, Small GW, Satyamurthy N, Barrio JR.

Methods Enzymol. 2006;412:144-60. Review.

PMID:
17046657
9.

Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET.

Barthel H, Sabri O.

J Alzheimers Dis. 2011;26 Suppl 3:117-21. doi: 10.3233/JAD-2011-0068. Review.

PMID:
21971456
10.

Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.

Tu P, Fu H, Cui M.

Expert Opin Ther Pat. 2015 Apr;25(4):413-23. doi: 10.1517/13543776.2015.1007953. Epub 2015 Mar 8. Review.

PMID:
25746836
11.

Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.

Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):362-73. doi: 10.1007/s00259-015-3208-1. Epub 2015 Oct 6. Review.

PMID:
26440450
12.

Current status of PET-imaging probes of β-amyloid plaques.

Koo J, Byun Y.

Arch Pharm Res. 2013 Oct;36(10):1178-84. doi: 10.1007/s12272-013-0193-4. Epub 2013 Jul 1. Review.

PMID:
23812777
13.

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S.

Amyloid. 2014 Sep;21(3):143-8. doi: 10.3109/13506129.2014.926267. Epub 2014 Jun 11. Review.

PMID:
24919109
14.

The prognostic value of amyloid imaging.

Gelosa G, Brooks DJ.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1207-19. doi: 10.1007/s00259-012-2108-x. Epub 2012 Apr 11. Review.

PMID:
22491780
15.

Amyloid plaque imaging from IMPY/SPECT to AV-45/PET.

Kung MP, Weng CC, Lin KJ, Hsiao IT, Yen TC, Wey SP.

Chang Gung Med J. 2012 May-Jun;35(3):211-8. Review.

PMID:
22735052
16.

Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.

Scheinin NM, Scheinin M, Rinne JO.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):265-79. Review.

PMID:
21532540
17.

5-[18F]Fluoro-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-oxazolo[5,4-b]pyridine.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Dec 20 [updated 2012 Feb 16].

18.

[Molecular PET imaging for in vivo detection of amyloid in the human brain].

Okamura N.

Rinsho Shinkeigaku. 2009 Nov;49(11):922-4. Review. Japanese.

PMID:
20030249
19.

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC.

Mol Neurobiol. 2008 Aug;38(1):1-15. doi: 10.1007/s12035-008-8019-y. Epub 2008 Aug 9. Review.

PMID:
18690556
20.

PET studies in dementia.

Herholz K.

Ann Nucl Med. 2003 Apr;17(2):79-89. Review.

PMID:
12790355

Supplemental Content

Support Center